<DOC>
	<DOCNO>NCT01279915</DOCNO>
	<brief_summary>A study evaluate safety , tolerability , pharmacokinetics pharmacodynamics single ascend dose ASP0456 non-elderly healthy subject .</brief_summary>
	<brief_title>A Safety Pharmacokinetics Study ASP0456 Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy , judge investigator/subinvestigator base result physical examination test obtain Body weight ( screen ) ; ≥50.0 kg , &lt; 80.0 kg BMI ( screen ) : ≥17.6 , &lt; 26.4 Received investigational drug clinical postmarketing study within 120 day study Donated 400 mL whole blood within 90 day , 200 mL whole blood within 30 day , blood component within 14 day study Received medication within 10 day dose administer schedule receive medication History drug allergy Upper ( e.g . nausea , vomit , stomachache ) low ( e.g . abdominal pain ) gastrointestinal disease within 7 day study Concurrent previous hepatic disease Concurrent previous heart disease Concurrent previous renal disease</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>ASP0456</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
</DOC>